Jianping Chen

Antitumor activity of SCH 66336, an orally bioavailable tricyclic inhibitor of farnesyl protein transferase, in human tumor xenograft models and wap-ras transgenic mice.

Ming Liu, Matthew Bryant, Jianping Chen et al. · PubMed · 1998 · 309 citations

Medicine, Medicinal Chemistry, Pharmacology +15

TC2N, a novel oncogene, accelerates tumor progression by suppressing p53 signaling pathway in lung cancer

Xianglin Hao, Fei Han, Ning Zhang et al. · Cell Death and Differentiation · 2018 · 76 citations · Full text

Medicine, Cancer Biology, Oncology +17

Berberine Inhibits Growth and Induces G1 Arrest and Apoptosis in Human Cholangiocarcinoma QBC939 Cells

Wei He, Bin Wang, Yun Zhuang et al. · Journal of Pharmacological Sciences · 2012 · 49 citations · Full text

Medicine, Oncology, Pharmacology +13

Comprehensive molecular profiling of the B7 family of immune-regulatory ligands in breast cancer

Zhenyu Xu, Jing Shen, Maggie Haitian Wang et al. · OncoImmunology · 2016 · 40 citations · Full text

Life Sciences, Immunology, Oncology +17

Combination therapy with the farnesyl protein transferase inhibitor SCH66336 and SCH58500 (p53 adenovirus) in preclinical cancer models.

Loretta L. Nielsen, Bin Shi, Gerald Hajian et al. · PubMed · 1999 · 36 citations

Medicine, Oncology, Pharmacology +13